Gottlieb: Shortened quarantine would capture "vast majority" of cases
The former FDA commissioner says a seven- or 10-day recommended quarantine period would lead more Americans to comply.
Watch CBS News
The former FDA commissioner says a seven- or 10-day recommended quarantine period would lead more Americans to comply.
CBS News has confirmed that United Airlines is using chartered flights to distribute Pfizer's upcoming coronavirus vaccine. The FDA will consider emergency use approval in December. Kris Van Cleave takes a closer look.
Moderna is asking the FDA to grant emergency use authorization for its coronavirus vaccine, as hospitalizations hit record highs across the U.S. Dr. Ogechika Alozie joins CBSN from El Paso, Texas, to give his take on the vaccine news and the current state of the pandemic.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired November 29, 2020, on "Face the Nation."
Health secretary said the White House task force is now in communication with Mr. Biden's transition team.
On Friday, pharmaceutical company Pfizer became the first company to submit a coronavirus vaccine to the U.S. Food and Drug Administration for an emergency use authorization. Dr. James Phillips, Chief of Disaster Medicine at George Washington University Hospital, walks CBSN through what the approval process entails.
The former FDA commissioner says young, healthy Americans should expect to be able to get vaccinated by the second or third quarter of next year.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired November 22, 2020, on "Face the Nation."
With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.
Scientists working with AstraZeneca say they're "delighted" with the latest human trial data, but they're "not in a rush."
It's the latest hopeful news for a world desperate to turn the tide on the coronavirus pandemic that has killed more than 1.3 million people globally, and almost 250,000 in the U.S. alone.
The test will require a prescription, likely limiting its initial use.
Moderna says their COVID vaccine highly successful; FBI: massive rise in hate crimes in 2019
American pharmaceutical company Moderna announced on Monday that its COVID-19 vaccine candidate is nearly 95% effective. The news comes one week after Pfizer announced its inoculations are also successful. CBS News chief medical correspondent Dr. Jon LaPook has the latest.
Moderna says it has developed a coronavirus vaccine that's nearly 95% effective, and with emergency approval from the FDA it could start distributing the shots to high-risk patients and health care workers as soon as December. Dr. Jon LaPook reports.
Preliminary results show a 94.5% effectiveness rate for Moderna's coronavirus vaccine in Phase 3 trials. The company expects to request emergency use authorization from the FDA within a few weeks. Dr. Jon LaPook reports.
"My biggest fear is that we're dealing with a surge at the same time that we're trying to vaccinate," said New Jersey Health Commissioner Judith Persichilli.
Early results suggest it may help clear the coronavirus sooner and possibly cut hospitalizations in people with mild to moderate COVID-19.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired November 8, 2020, on "Face the Nation."
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired November 1, 2020, on "Face the Nation."
Nearly all planned 44,000 participants enrolled in final-stage trial. If found safe, vaccine could see use in November.
The earliest a coronavirus vaccine is expected to be ready for FDA authorization is the end of November. The CDC has already given states $200 million to prepare for vaccine distribution — but will that be enough? Dr. Tara Narula finds out whether the U.S. has the infrastructure in place to safely and efficiently get people the vaccine.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired October 25, 2020, on "Face the Nation."
The Food and Drug Administration has approved remdesivir for the treatment of the coronavirus, and it comes as some cities across the country are seeing spikes in COVID-19 cases. Janet Shamlian reports.
The plea bargain does not foreclose future criminal charges against the Sackler family owners and Purdue's executives. 60 Minutes has covered the opioid epidemic extensively.